首页> 外文OA文献 >Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study

【2h】

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study

机译：Her2阳性转移性乳腺癌患者的Lapatinib和治疗后的Lapatinib和治疗的真实数据：多中心，回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yizhao Xie; Rui Ge; Die Sang; Ting Luo; Wei Li; Xuening Ji; Peng Yuan; Biyun Wang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study [J] . Yizhao Xie, Rui Ge, Die Sang, Cancer Medicine . 2020,第9期

机译：Her2阳性转移性乳腺癌患者的Lapatinib和治疗后的Lapatinib和治疗的真实数据：多中心，回顾性研究
2. Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study [J] . Yi Li, Chengcheng Gong, Qianyi Lu, Frontiers in Oncology . 2020,第4期

机译：Trastuzumab，Lapatinib和Her2阳性转移性乳腺癌中的三联组合的真实数据：多中心回顾性研究
3. Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study [J] . PestrinM., BessiS., PuglisiF., Breast cancer research and treatment. . 2012,第1期

机译：多中心II期临床试验的最终结果，该试验评估了单药拉帕替尼在HER2阴性转移性乳腺癌和HER2阳性循环肿瘤细胞中的活性。概念验证研究
4. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter retrospective study [O] . Yizhao Xie, Rui Ge, Die Sang, 2020

机译：先前治疗过的HER2阳性转移性乳腺癌患者的拉帕替尼及其治疗后的真实数据：一项多中心回顾性研究
7. Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study [O] . Yi Li, Chengcheng Gong, Qianyi Lu, 2020

机译：Trastuzumab，Lapatinib和Her2阳性转移性乳腺癌中的三联组合的真实数据：多中心回顾性研究

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study

著录项

相似文献

相关主题

期刊订阅